Evaluation of the Role of Human Papillomavirus Testing and p16 Expression in the Management of Patients Undergoing Cervical Cancer Screening
The principal hypothesis of this study is that HPV testing and/or p16 testing, either alone
or in combination or associated with a Pap smear, will demonstrate greater specificity for
clinically significant precancerous disease than will a Pap smear alone and that these tests
will be of comparable or superior sensitivity than the Pap smear.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society